Intelligent Bio Solutions Inc.
NCM: INBSLive Quote
About Intelligent Bio Solutions Inc.
Healthcare
Medical Devices
Intelligent Bio Solutions Inc., a medical technology company, focused on developing and delivering non-invasive testing, and screening solutions in Asia Pacific, the United States, the United Kingdom, and internationally. The company operates intelligent fingerprinting drug screening system, a platform to analyze fingerprint sweat analysis to detect drugs abuse; and biosensor platform. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. Intelligent Bio Solutions Inc. was incorporated in 2016 and is headquartered in New York, New York.
📊 Fundamental Analysis
Intelligent Bio Solutions Inc. demonstrates a profit margin of 0.0%, which is below the sector average, suggesting competitive pressure.
The company recently reported 47.6% revenue growth, which is well above average for the Healthcare sector.
Return on Equity (ROE) is -150.2%, which indicates that capital utilization is currently under pressure.
At a current price of $2.46, INBS currently trades near the bottom of its 52-week range (0%), indicating potential value or weakness (Range: $2.46 - $24.90).
🏥 Financial Health
🔴
Profit Margin
Weak
✅
Debt/Equity
Excellent
✅
Revenue Growth
Excellent
🔴
Return on Equity
Weak
🔴
Beta (Risk)
High Volatility
Key Financials
Market Cap
$5.79M
Trailing P/E
--
Forward P/E
7.03
Beta (5Y)
4.59
52W High
$24.90
52W Low
$2.46
Avg Volume
128K
Day High
Day Low
📡 Subscribe to ZcoreAI updates
Join the list to get access to:
- Z-Score signals at market open
- New app features and updates
- Exclusive promo for ZcoreAI App